search
Back to results

Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients

Primary Purpose

Depression, Anxiety, Cancer

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Beating the Blues (BtB)
Entertain Me Well (EMW)
Coaching
Sponsored by
University of Michigan Rogel Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Depression, Anxiety

Eligibility Criteria

15 Years - 25 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Cancer survivor, either receiving active treatment or completed cancer treatment
  • Experiencing depression and anxiety as measured by PHQ-9 or GAD-7

Exclusion Criteria:

  • Severe medical or mental condition (e.g. suicidal ideation)
  • Medical condition that prevents patients from operating a computer or tablet
  • Receiving end-of-life care

Sites / Locations

  • University of Michigan Rogel Cancer Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Coach-assisted C-CBT with BtB

Coach-assisted animated C-CBT with EMW

Standard stand-alone C-CBT with BtB

Arm Description

Participants will receive coach- assisted Beating the Blues (BtB), a C- CBT program, which contains 8 weekly sessions. A coach will provide between session support throughout the 8 sessions.

Participants will receive coach- assisted Entertain Me Well (EMW), an animated C-CBT program, which contains 8 weekly sessions. A coach will provide between session support throughout the 8 sessions.

Participants will use the stand-alone BtB for 8 weekly sessions, without coach assistance.

Outcomes

Primary Outcome Measures

Rate of C-CBT completion
Percentage of participants in each arm who complete at least 6 out of 8 sessions, as measured by online service usage data.
Percentage of participants who confirm acceptability of the intervention during interviews
Participants will be interviewed about their perceptions regarding the delivery format, treatment content, and other treatment related factors. Qualitative interviews will be transcribed by research staff and coded using thematic content analysis and axial coding. Qualitative data will be reviewed iteratively until saturation is reached, that is when no new information seems to emerge during coding. Emergence or non-emergence of acceptability theme will be assessed. Findings will be descriptive and will include the percentage of participants who confirm acceptability.

Secondary Outcome Measures

Change in level of depression from baseline to end of intervention
The Patient Health Questionnaire, 9 -item (PHQ-9) is a validated brief measure of depression. Participants will answer the questionnaire at their baseline assessment, at the beginning of each session, and at their post-intervention assessment.
Change in level of anxiety from baseline to end of intervention
The Generalized Anxiety Disorder, 7-item (GAD-7) is a validated brief measure of anxiety. Participants will answer the questionnaire at their baseline assessment and at their post-intervention assessment.
Change in level of distress from baseline to end of intervention
The Brief Symptom Inventory, 18-item (BSI-18) is a validated distress screening tool especially for cancer patients. Participants will answer the questionnaire at their baseline assessment and at their post-intervention assessment.
Change in level of self-efficacy from baseline to end of intervention
The PROMIS Self-Efficacy for Managing Chronic Conditions (PROMIS SM Scale) is a 28-item validated tool to assess patients' self-efficacy in managing their chronic condition symptoms.
Change in level of involvement and participation in health care from baseline to end of intervention
The Patient Activation Measure (PAM) is a 13-item validated tool to evaluate patients' involvement and participation in their health care. Participants will answer the questionnaire at their baseline assessment and at their post-intervention assessment.

Full Information

First Posted
February 23, 2021
Last Updated
December 16, 2021
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
St. Baldrick's Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT04773197
Brief Title
Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients
Official Title
Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Terminated
Why Stopped
Low accrual
Study Start Date
November 30, 2020 (Actual)
Primary Completion Date
August 3, 2021 (Actual)
Study Completion Date
August 3, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Michigan Rogel Cancer Center
Collaborators
St. Baldrick's Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This project's overall goal is to test the feasibility, acceptability and efficacy of two coach-assisted, computer-based, cognitive- behavioral therapy (C-CBT) interventions in treating depression and anxiety in adolescent and young adult cancer survivors. The two coach-assisted interventions will be compared to the standard C-CBT intervention.
Detailed Description
This will be a three-arm randomized controlled trial with two treatment arms and one control arm. Participants in the first treatment arm will receive a coach-assisted C-CBT intervention called "Beating the Blues" (BtB). A second treatment arm will receive a coach-assisted, animated C-CBT intervention called "Entertain Me Well" (EMW). Both treatment arms will have 8 weekly sessions that contain core components of CBT. A coach will provide between-session support throughout the 8 sessions. The control arm will use the standard care of BtB without coach assistance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety, Cancer

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study is a three-arm, prospective randomized controlled trial with participants being randomly assigned into one of the three groups: (1) coach-assisted BtB intervention (treatment condition 1), (2) coach-assisted animated EMW (treatment condition 2), and (3) standard BtB (control group).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Coach-assisted C-CBT with BtB
Arm Type
Experimental
Arm Description
Participants will receive coach- assisted Beating the Blues (BtB), a C- CBT program, which contains 8 weekly sessions. A coach will provide between session support throughout the 8 sessions.
Arm Title
Coach-assisted animated C-CBT with EMW
Arm Type
Active Comparator
Arm Description
Participants will receive coach- assisted Entertain Me Well (EMW), an animated C-CBT program, which contains 8 weekly sessions. A coach will provide between session support throughout the 8 sessions.
Arm Title
Standard stand-alone C-CBT with BtB
Arm Type
Active Comparator
Arm Description
Participants will use the stand-alone BtB for 8 weekly sessions, without coach assistance.
Intervention Type
Behavioral
Intervention Name(s)
Beating the Blues (BtB)
Intervention Description
Beating the Blues (BtB) is a C-CBT intervention with 8 weekly sessions to be completed within 10 weeks.
Intervention Type
Behavioral
Intervention Name(s)
Entertain Me Well (EMW)
Intervention Description
Entertain Me Well (EMW) is is a C-CBT intervention with 8 weekly sessions to be completed within 10 weeks.
Intervention Type
Behavioral
Intervention Name(s)
Coaching
Intervention Description
A coach will spend approximately 5-10 minutes after each session with the patient to link the C-CBT content with patient's disease specific experiences and to motivate them to continue the program. They will also spend approximately 5 minutes between sessions to motivate a patient to complete assignments and to remind them about starting the next session on time.
Primary Outcome Measure Information:
Title
Rate of C-CBT completion
Description
Percentage of participants in each arm who complete at least 6 out of 8 sessions, as measured by online service usage data.
Time Frame
10 weeks
Title
Percentage of participants who confirm acceptability of the intervention during interviews
Description
Participants will be interviewed about their perceptions regarding the delivery format, treatment content, and other treatment related factors. Qualitative interviews will be transcribed by research staff and coded using thematic content analysis and axial coding. Qualitative data will be reviewed iteratively until saturation is reached, that is when no new information seems to emerge during coding. Emergence or non-emergence of acceptability theme will be assessed. Findings will be descriptive and will include the percentage of participants who confirm acceptability.
Time Frame
10 weeks
Secondary Outcome Measure Information:
Title
Change in level of depression from baseline to end of intervention
Description
The Patient Health Questionnaire, 9 -item (PHQ-9) is a validated brief measure of depression. Participants will answer the questionnaire at their baseline assessment, at the beginning of each session, and at their post-intervention assessment.
Time Frame
10 weeks
Title
Change in level of anxiety from baseline to end of intervention
Description
The Generalized Anxiety Disorder, 7-item (GAD-7) is a validated brief measure of anxiety. Participants will answer the questionnaire at their baseline assessment and at their post-intervention assessment.
Time Frame
10 weeks
Title
Change in level of distress from baseline to end of intervention
Description
The Brief Symptom Inventory, 18-item (BSI-18) is a validated distress screening tool especially for cancer patients. Participants will answer the questionnaire at their baseline assessment and at their post-intervention assessment.
Time Frame
10 weeks
Title
Change in level of self-efficacy from baseline to end of intervention
Description
The PROMIS Self-Efficacy for Managing Chronic Conditions (PROMIS SM Scale) is a 28-item validated tool to assess patients' self-efficacy in managing their chronic condition symptoms.
Time Frame
10 weeks
Title
Change in level of involvement and participation in health care from baseline to end of intervention
Description
The Patient Activation Measure (PAM) is a 13-item validated tool to evaluate patients' involvement and participation in their health care. Participants will answer the questionnaire at their baseline assessment and at their post-intervention assessment.
Time Frame
10 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cancer survivor, either receiving active treatment or completed cancer treatment Experiencing depression and anxiety as measured by PHQ-9 or GAD-7 Exclusion Criteria: Severe medical or mental condition (e.g. suicidal ideation) Medical condition that prevents patients from operating a computer or tablet Receiving end-of-life care
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anao Zhang, Ph.D.
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Michigan Rogel Cancer Center
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients

We'll reach out to this number within 24 hrs